Case study of the anemic patient: epoetin alfa--focus on erythrokinetics.
Erythrokinetics is a physiologic process that regulates red blood cell dynamics. In keeping with the present trend of focusing on patient outcomes and costs, an erythrokinetic model provides a guideline for appropriate dosing of Epoetin alfa to maintain a hematocrit within the target range of 30% to 36%. Maintaining the patient's hematocrit at the optimal level influences patient outcomes by enhancing the quality of life and improving patient management by decreasing time and costs.
Chmielewski
C M
CM
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D016903:Drug Monitoring; D004921:Erythropoietin / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*
D004921:Erythropoietin